Debut creates natural ingredients using advanced biomanufacturing tools. Debut Biotech is a biotechnology company that focuses on providing specialty enzyme solutions combined with continuous manufacturing. It combines the power of enzymes with continuous manufacturing to create and modify small and large molecules for a wide range of industries and applications.
We help the pharmaceutical and specialty chemical industries manufacture high-value molecules by combining custom-designed immobilized enzymes with continuous biomanufacturing processes. Our cell-free platform has the ability to transform low-value bio-renewable materials into high-value therapeutics and specialty chemicals.
Total Funding: $3.6 M
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2019
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Debut Biotech
